Story perspectives

Walgreens Settles for $300M Over Opioid Prescription Violations

4/22/2025

30 5

Summary

Story summary

Walgreens will pay $300 million for illegally filling opioid prescriptions, with an additional $50 million if sold before 2032.
Allegations include pressuring pharmacists to overlook red flags and legitimate medical purposes.
The company must adopt compliance measures, including annual training and stricter prescription verification.
Whistleblowers will receive 17.25% of the settlement amount from the lawsuits.
This settlement marks one of the largest in Controlled Substances Act history, highlighting efforts to combat the opioid crisis.

1 of 1

Story summary

Walgreens will pay $300 million for illegally filling opioid prescriptions, with an additional $50 million if sold before 2032.
Allegations include pressuring pharmacists to overlook red flags and legitimate medical purposes.
The company must adopt compliance measures, including annual training and stricter prescription verification.
Whistleblowers will receive 17.25% of the settlement amount from the lawsuits.
This settlement marks one of the largest in Controlled Substances Act history, highlighting efforts to combat the opioid crisis.